- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bio-Rad Laboratories Inc (BIO)
Bio-Rad Laboratories Inc stock price live, this page displays NYSE BIO stock exchange data. View the BIO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bio-Rad Laboratories Inc real time stock price chart below.
What Is the Bio-Rad Laboratories Inc Stock Price Today?
The Bio-Rad Laboratories Inc stock price today is 245.18.
What Is the Stock Symbol for Bio-Rad Laboratories Inc?
The stock ticker symbol for Bio-Rad Laboratories Inc is BIO.
Is BIO the Same as $BIO?
$BIO is a common way to refer to the Bio-Rad Laboratories Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Bio-Rad Laboratories Inc Trade On?
Bio-Rad Laboratories Inc is listed and trades on the NYSE stock exchange.
Is Bio-Rad Laboratories Inc a Good Stock to Buy?
Determining whether Bio-Rad Laboratories Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Bio-Rad Laboratories Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIO quote. (ISIN: US0905722072)
What Is the Bio-Rad Laboratories Inc Stock Price Today?
The Bio-Rad Laboratories Inc stock price today is 245.18.
What Is the Stock Symbol for Bio-Rad Laboratories Inc?
The stock ticker symbol for Bio-Rad Laboratories Inc is BIO.
Is BIO the Same as $BIO?
$BIO is a common way to refer to the Bio-Rad Laboratories Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Bio-Rad Laboratories Inc Trade On?
Bio-Rad Laboratories Inc is listed and trades on the NYSE stock exchange.
Is Bio-Rad Laboratories Inc a Good Stock to Buy?
Determining whether Bio-Rad Laboratories Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Bio-Rad Laboratories Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BIO quote. (ISIN: US0905722072)
245.29
+2.10(+0.86%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
239.75
245.37
52 wk Range
215.38
387.99
BIO Scorecard
Full Analysis
Management has been aggressively buying back shares
BIO is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
239.75245.37
52 wk Range
215.38387.99
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BIO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
318.67
Upside
+29.91%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
- Bio-Rad Reports First-Quarter 2025 Financial Results
- Investing.com
- Bio-Rad Labs beats Q1 estimates, lowers 2025 outlook
- Investing.com
Bio-Rad Laboratories Inc Company Profile
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Bio-Rad Laboratories Inc SWOT Analysis
Growth Prospects | Analyst targets suggest up to 21% upside, with price ranges from $400 to $469, reflecting confidence in Bio-Rad's margin expansion potential |
Operational Challenges | Delve into Bio-Rad's strategic responses to product launch delays and macroeconomic pressures in the Life Science Tools secto |
Tech Advancements | Explore Bio-Rad's digital droplet PCR technology resurgence and its potential impact on revenue expansion and market positioning |
Financial Resilience | Bio-Rad demonstrates robust financial health with strong EBITDA and current ratio, surpassing estimates despite market headwinds |
Bio-Rad Laboratories Inc Earnings Call Summary for Q1/2025
- Bio-Rad exceeds Q1 2025 EPS expectations with $2.54 vs $1.80 forecast; revenue slightly above estimates at $585.4 million
- Stock rises 1.9% after-hours; company maintains strong financial health with 'GOOD' overall score from InvestingPro
- Non-GAAP operating margin improves to 10.8% from 9.7% YoY; free cash flow increases to $96 million from $30 million in Q1 2024
- Full-year guidance: -1% to +1.5% currency-neutral revenue growth; non-GAAP operating margin of 10-12% despite potential tariff headwinds
- CEO emphasizes ongoing corporate transformation; CFO notes conservative demand outlook amid market uncertainties
Last Updated: 05/01/2025, 06:24 PM
Read Full TranscriptCompare BIO to Peers and Sector
Metrics to compare | BIO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBIOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.1x | −2.7x | −0.5x | |
PEG Ratio | 0.01 | 0.12 | 0.00 | |
Price / Book | 1.0x | 1.1x | 2.6x | |
Price / LTM Sales | 2.6x | 1.8x | 2.9x | |
Upside (Analyst Target) | 33.8% | 83.7% | 45.8% | |
Fair Value Upside | Unlock | 31.4% | 8.6% | Unlock |
Analyst Ratings
4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 318.67
(+29.91% Upside)
Earnings
Latest Release
May 01, 2025
EPS / Forecast
2.54 / 1.80
Revenue / Forecast
585.40M / 573.22M
People Also Watch
FAQ
What Is the Bio-Rad Labs (BIO) Stock Price Today?
The Bio-Rad Labs stock price today is 245.29
What Stock Exchange Does Bio-Rad Labs Trade On?
Bio-Rad Labs is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Bio-Rad Labs?
The stock symbol for Bio-Rad Labs is "BIO."
What Is the Bio-Rad Labs Market Cap?
As of today, Bio-Rad Labs market cap is 6.63B.
What Is Bio-Rad Labs's Earnings Per Share (TTM)?
The Bio-Rad Labs EPS (TTM) is -77.10.
When Is the Next Bio-Rad Labs Earnings Date?
Bio-Rad Labs will release its next earnings report on Jul 24, 2025.
From a Technical Analysis Perspective, Is BIO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.